Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

Author

Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Executive Director

Title Created Date Category
Pharmacological therapeutics in Friedreich Ataxia: The present state Friday, July 21, 2017 Funded Research
Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model Friday, July 21, 2017 Funded Research
Cal for Abstracts - 10th Annual Friedreich’s Ataxia Symposium Thursday, July 20, 2017 Scientific News
AFAF and FARA invite proposals for research projects that advance drug discovery, development of novel biomarkers or improve clinical outcomes in Friedreich’s ataxia patients Sunday, July 16, 2017 Funded Research
Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients Friday, July 14, 2017 Scientific News
How does performance of the Friedreich Ataxia Functional Composite compare to rating scales? Wednesday, July 12, 2017 Funded Research
Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency Wednesday, June 7, 2017 Funded Research
Reata Pharmaceuticals, Inc. Announces Positive Data From Part One of Moxie Trial of Omaveloxolone for Friedreich’s Ataxia Thursday, June 1, 2017 Supported Research
Cerebral compensation during motor function in Friedreich ataxia: The IMAGE-FRDA study Wednesday, May 31, 2017 Scientific News
Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy Friday, May 26, 2017 Funded Research

SHARE

FacebookTwitterLinkedinShare on Google+
Family D.jpg